Wednesday, April 23, 2025

Yearly Archives: 2020

Coronavirus (COVID-19) Update: Daily Roundup May 8, 2020

May 08, 2020: The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19...

FDA Approves First Therapy for Patients with Lung and Thyroid Cancers

May 08, 2020: "The U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung...

U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study

May 8, 2020: "Pluristem Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s IND application for a Phase...

PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic

May 6, 2020: "PharmaCyte Biotech announced that it has received Medical Devices Establishment Registration with the FDA’s Center for Devices and Radiological Health (CDRH)....

RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study

May 08, 2020: "RedHill Biopharma Ltd. announced that the U.S.FDA has approved its IND application for a Phase 2a clinical study evaluating its investigational drug,...

Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study

May 06, 2020: "Amgen announced positive top-line results from the ADVANCE trial, a Phase 3, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy of...

FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

May 8, 2020: "Amgen and Cytokinetics, Incorporated announced that the U.S.FDA has granted Fast Track designation for omecamtiv mecarbil, a novel selective cardiac myosin activator, also known as...

CDC scientists honored as 2020 Service to America Medal Finalists

May 08, 2020: "Centers for Disease Control and Prevention Control (CDC) scientists Dr. Vikram Krishnasamy, and Dr. Peter Briss and the 2019 Lung...

Gilead Announces Approval of Veklury® (remdesivir) in Japan

May 7, 2020: "Gilead Sciences, Inc. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a treatment...

Preliminary positive results seen for microbiome-based C. diff treatment

May 07, 2020: "A new microbiome-based treatment for Clostridioides difficile infection showed success in reducing recurrence of the infection at 8 weeks, according to preliminary results released...

Imperial College volunteers find innovative ‘Hackspace’ solution

May 05, 2020: "Volunteers at Imperial College London are making more than 50,000 disposable visors for Imperial College Healthcare NHS Trust hospitals. In partnership with...

New data at the ASCO20 reflects Roche’s commitment to cancer care

May 07, 2020: "Roche announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented...
- Advertisment -

Most Read